Your browser doesn't support javascript.
loading
Therapeutic Potential of a Prolyl Hydroxylase Inhibitor FG-4592 for Parkinson's Diseases in Vitro and in Vivo: Regulation of Redox Biology and Mitochondrial Function.
Li, Xuan; Cui, Xin-Xin; Chen, Ya-Jing; Wu, Ting-Ting; Xu, Huaxi; Yin, Huiyong; Wu, Yun-Cheng.
Afiliação
  • Li X; Department of Neurology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Cui XX; Department of Neurology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Chen YJ; Department of Neurology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Wu TT; Department of Neurology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Xu H; Neuroscience Initiative, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, United States.
  • Yin H; Key Laboratory of Food Safety Research, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, China.
  • Wu YC; Key Laboratory of Food Safety Risk Assessment, Ministry of Health, Beijing, China.
Front Aging Neurosci ; 10: 121, 2018.
Article em En | MEDLINE | ID: mdl-29755339
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Aging Neurosci Ano de publicação: 2018 Tipo de documento: Article País de afiliação: China País de publicação: Suíça
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Aging Neurosci Ano de publicação: 2018 Tipo de documento: Article País de afiliação: China País de publicação: Suíça